NCT06546358View on ClinicalTrials.gov

Quetiapine Versus Trazadone in Women With Postpartum Depression

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 30, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2025

Conditions
Postpartum Depression
Interventions
DRUG

Trazodone

Participants will be randomized to receive either quetiapine or trazodone.

DRUG

Quetiapine

Participants will be randomized to receive either quetiapine or trazodone.

Trial Locations (1)

N6V 0A7

Parkwood Institute, London

All Listed Sponsors
lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

NCT06546358 - Quetiapine Versus Trazadone in Women With Postpartum Depression | Biotech Hunter | Biotech Hunter